This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Zealand Pharma A/s. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Henrik Fischer Munch: Innovator in Potassium Channel Blockers
Introduction
Henrik Fischer Munch is a notable inventor based in Søborg, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of potassium channel blockers. With a total of 2 patents, Munch's work has the potential to impact various therapeutic areas.
Latest Patents
Munch's latest patents focus on Kv1.3 blockers. The present invention provides novel blockers of the potassium channel Kv1.3, polynucleotides encoding them, and methods of making and using them. This innovation is crucial for advancing treatments related to immune responses and other physiological processes.
Career Highlights
Throughout his career, Henrik Fischer Munch has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Zealand Pharma A/S and ZP SPV 3 K/S. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Munch has collaborated with several professionals in his field, including Rasmus Bugge Jensen and Jens Kvist Madsen. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Henrik Fischer Munch is a distinguished inventor whose work on Kv1.3 blockers showcases his commitment to innovation in biochemistry. His contributions are poised to make a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile